Neurodegenerative Diseases: pathogenic mechanisms

2024 Activity indicators

7 public competitive projects led: ISCIII, MICINN, CIBERNED
1 private competitive project and 1 private non-competitive project
led
5 HR competitive contracts
5 publications
IF: 30.80
Q1 publications: 5 (100%)
D1 publications: 2 (40%)
Project evaluators: 2 PI
Members of editorial committees: 2 PI
1 visitor hosted and 5 months stay:
- National Autonomous University of Mexico (UNAM)
11 months stay in foreign centres:
- EMBL-European Molecular Biology Laboratory
1 European patent maintained. Number EP2733205, on methods of neural stem cell differentiation by modulation of CB1.

Milestones

Costas C, Hermoso A, Moreno E, Montero C, Álvaro A, Maroto IB, Sánchez A, Díez R, Blázquez C, Morales P, Canela EI, Casadó V, Urigüen L, Perea G, Bellocchio L, Rodríguez I, Guzmán M. The CB(1) receptor interacts with cereblon and drives cereblon defi ciency-associated memory shortfalls. EMBO Mol Med. 2024;16(4): 755 - 783. DOI:10.1038/s44321- 024-00054-w.
Maroto IB, Costas C, Montero C, Hermoso A, Lebouc M, Bajo R, Álvaro A, Blázquez C, Cannich A, Marsicano G, Martín R, Baufreton J, Rodríguez I, Bellocchio L, Guzmán M. GAP43 Located on Corticostriatal Terminals Restrains NoveltyInduced Hyperactivity in Mice. J. Neurosci. 2024;44(39): e0701242024. DOI:10.1523/JNEUROSCI.0701-24.2024.
Sánchez de la Torre A, Ezquerro S, Huerga A, Sánchez E, Chara JC, Matute C, Monory K, Mato S, Lutz B, Guzmán M, Aguado T, Palazuelos J. CB(1) receptors in NG2 cells mediate cannabinoid-evoked functional myelin regeneration. PROG NEUROBIOL. 2024;243: 102683 - 102683. DOI:10.1016/j. pneurobio.2024.102683.
Tundidor I, Seijo M, Blasco S, Rubert M, Moreno G, Bindila L, de la Rosa RF, Guzmán M, Sánchez C, Pérez E. Fatty acid amide hydrolase drives adult mammary gland development by promoting luminal cell diff erentiation. Cell Death Discov. 2024;10(1): 12 - 12. DOI:10.1038/s41420-023-01788-1.
Quintero JM, Díaz LE, Galve I, Bustos RH, Leon MX, Beltrán S, Dodd S. The endocannabinoid system as a therapeutic target in neuropathic pain: a review. Expert Opin. Ther. Targets. 2024;28(9): 739 - 755. DOI:10.1080/14728222.2024.2407824.

Bibliometrics

	Articles	Accum. IF	Mean IF	Articles QI or Q2	% in Q1 or Q2	Articles D1	% in D1
2020	10	128.66	12.87	10	100	7	70
2021	6	36.42	6.07	5	83	2	33
2022	2	13.23	6.61	2	100	1	50
2023	7	76.20	10.89	7	100	3	43
2024	5	30.80	6.16	5	100	2	40
	30	285.31	8.52	29	97	15	50